Resources from the same session
How to handle bias in study design and reporting for ESMO-MCBS grading
Presenter: Nathan Cherny
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
Progression-free survival: Should it be used as a primary end point for registration of anticancer treatments and what is the role of the ESMO-MCBS?
Presenter: Bishal Gyawali
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
ESMO-MCBS coming of age: can we extend beyond registration studies?
Presenter: Sjoukje Oosting
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
EU HTA Regulation: State of play for cancer medicines
Presenter: Maya Matthews
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Nathan Cherny
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Webcast